Joshua Reiser

Joshua Reiser is an Associate Scientist at Regel Therapeutics, a position held since February 2023. Prior to this role, Joshua served as a Senior Research Associate at Remix Therapeutics from June to November 2022 and as an Associate Scientist at 4:59 NewCo, a 5AM Ventures Company, from February 2021 to June 2022. Experience also includes working at Biogen as an Associate Scientist II in Technical Development from February 2020 to February 2021 and at Solid Biosciences as an Associate Scientist in Analytical Development for a brief period in late 2019. Joshua's academic background includes a Master of Science in Biology from The City College of New York and a Bachelor's degree in Biology from Hunter College. Additionally, a Master's thesis project was conducted at The City College of New York, and experience as a lab intern was gained at Hunter College.